Alyeska Investment Group, L.P. Inari Medical, Inc. Transaction History

Alyeska Investment Group, L.P.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$56.23 - $71.17 $12.6 Million - $16 Million	-224,713 Reduced 40.72%	327,145 $19 Million
Q1 2023 May 15, 2023	BUY	$53.43 - $68.12 $29.5 Million - $37.6 Million	551,858 New	551,858 $34.1 Million
Q2 2021 Aug 16, 2021	BUY	$79.62 - $114.85 $1.04 Million - $1.51 Million	13,108 Added 27.02%	61,628 $5.75 Million
Q1 2021 May 17, 2021	SELL	$77.91 - $125.92 $145,691 - $235,470	-1,870 Reduced 3.71%	48,520 $5.19 Million
Q4 2020 Feb 16, 2021	BUY	$60.0 - $87.29 $2.53 Million - $3.67 Million	42,098 Added 507.69%	50,390 $4.4 Million
Q3 2020 Nov 16, 2020	SELL	$47.53 - $82.76 $1.1 Million - $1.92 Million	-23,229 Reduced 73.69%	8,292 $572,000
Q2 2020 Aug 14, 2020	BUY	$42.51 - $52.46 $1.34 Million - $1.65 Million	31,521 New	31,521 $1.53 Million

261

56.2M

90.4K

27.3K

Ticker NARI
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 53,389,700
Market Cap $2.86B
Description
Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of ...

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

Stay updated on Alyeska Investment Group, L.P. with notifications on news.